top of page
Search Results
Results found for " Anna Birukova"
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
January 2022 ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated , active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main forms of ANCA-associated
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
November 2021 Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European
- 📰 GPCR Weekly News, November 13 to 19, 2023
Novartis Neurocrine Biosciences Announces Settlement of INGREZZA Abbreviated New Drug Application (ANDA
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Truong ME, Bilekova S, Choksi SP, Li W, Bugaj LJ, Xu K, et al.
bottom of page